Rigaku Raman Upgrades Handheld Analyzer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Rigaku Raman Upgrades Handheld Analyzer


Rigaku Raman Technologies announced an updated version of the FirstGuard handheld Raman analyzer at Pittcon 2013. The analyzer operates at 1064 nm wavelength, enabling it to identify a broader range of raw materials and provide very rapid validation in comparison to 785 nm wavelength excitation products. Features include an integrated bar code reader enabling for GMP Raw Material Identification applications, user account management, upgraded data reporting and archiving, and improved data and operator security to support integration into FDA regulated manufacturing environments, the company reports. The analyzer is equipped with an integrated vial holder and hot swappable lithium ion battery, and is configured with secure software for 21 CRF part 11 compliance.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications

Click here